Gene · 8438
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. | Ann Oncol | 2024 | 38417742 | PubTator, text mining | PubMed |
| Altered gene expression linked to germline dysfunction following exposure of Caenorhabditis elegans to DEET. | iScience | 2024 | 38299026 | PubTator, text mining | PubMed |
| Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer. | Heliyon | 2024 | 38298632 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| Novel Association of RAD54L Mutation with Müllerian Clear Cell Carcinoma of the Male Urethra: New Insights Regarding the Molecular Mechanisms of a Rare Tumour. | Curr Cancer Drug Targets | 2024 | 38279717 | PubTator, text mining | PubMed |
| Assessment of Genetic Stability in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Using Droplet Digital PCR. | Int J Mol Sci | 2024 | 38256178 | PubTator, text mining | PubMed |
| How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update. | Cancers (Basel) | 2024 | 38254807 | PubTator, text mining | PubMed |
| Alternative Lengthening of Telomeres in Yeast: Old Questions and New Approaches. | Biomolecules | 2024 | 38254712 | PubTator, text mining | PubMed |
| Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma. | Sci Rep | 2024 | 38243040 | PubTator, text mining | PubMed |
| E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma. | Medicine (Baltimore) | 2024 | 38241554 | PubTator, text mining | PubMed |
| Molecular cloning, subcellular localization, and rapid recruitment to DNA damage sites of chicken Ku70. | Sci Rep | 2024 | 38216643 | PubTator, text mining | PubMed |
| Development of PARP inhibitors in advanced prostate cancer. | Ther Adv Med Oncol | 2024 | 38205078 | PubTator, text mining | PubMed |
| A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations. | Diagn Pathol | 2024 | 38184614 | PubTator, text mining | PubMed |
| Human RAD52 stimulates the RAD51-mediated homology search. | Life Sci Alliance | 2024 | 38081641 | PubTator, text mining | PubMed |
| Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma. | J Cell Mol Med | 2024 | 38013642 | PubTator, text mining | PubMed |
| Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study. | Clin Cancer Res | 2024 | 37939124 | PubTator, text mining | PubMed |
| Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer. | Cancer Discov | 2024 | 37849038 | PubTator, text mining | PubMed |
| Disparate requirements for RAD54L in replication fork reversal. | bioRxiv | 2024 | 37546955 | PubTator, text mining | PubMed |
| Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer. | J Racial Ethn Health Disparities | 2024 | 36810713 | PubTator, text mining | PubMed |
| Gross Chromosomal Rearrangement at Centromeres. | Biomolecules | 2023 | 38254628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8438/papers?page=5